The Biotech That Has Almost Doubled in 2017 With the Potential to Boom Even More Post author:Sam Post published:November 21, 2017 Post category:BioPharma Keith Speights, writing for The Motley Fool, notes one biotech that’s booming. Source: BioSpace You Might Also Like MRI Interventions Announces $13.25 Million Private Placement May 25, 2017 Pfizer Alum's Banks $45 Million Series C May 22, 2017 Horizon Pharma Pays $145 Million For And Its Rare Eye Disease Drug May 7, 2017
